Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry (RE-PROVE)

NCT07279649 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT07279649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07279649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry (RE-PROVE)
Lead sponsor
W.L.Gore & Associates
Phase
Observational
Overall status
Recruiting
Start date
May 8, 2026
Completion date
January 31, 2031
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aorto-iliac occlusive disease (aiod), isolated artery aneurysms (iaa), trauma or iatrogenic vessel injury, visceral artery occlusive disease (vaod)